Organization: University Medical Discoveries Inc

Cytochroma Inc raises additional $21 million in VC

Privately held Cytochroma Inc, Markham ON, has received $21 million in venture capital financing to expand the development of potential products for vitamin D deficiency and other diseases related to chronic kidney disease. The latest funding brings the total raised since 2001 to $58 million and follows last year’s acquisition of Madison WI-based Proventiv Therapeutics…

Milestone makes second-round investment in Salpep

Salpep Biotechnology Inc has received a second round of financing from Milestone Medica Corp, raising its financing to date to $1 million. The Calgary-based firm’s successful completion of preclinical milestones triggered the funding, by showing the efficacy of its anti-inflammatory compounds in pre-clinical models of asthma. The new funding will allow Salpep to continue with…